Composition, Standardization and Chemical Profiling of Banisteriopsis caapi, a Plant for the Treatment of Neurodegenerative Disorders Relevant to Parkinson’s Disease
This chemical profiling study investigated the different formulations of ayahuasca and proposes that the identified compounds can serve as reliable markets for the potency/composition of ayahuasca brews.
Authors
- Wang, Y. H.
- Samoylenko, V.
- Tekwani, B. L.
Published
Abstract
Aim of the study: Primary objective of this study was to develop the process for preparing standardized extracts of Banisteriopsis caapi to achieve high potency for inhibition of human monoamine oxidases (MAO) and antioxidant properties. The aqueous extracts prepared from different parts of the plant collected from different geographical locations and seasons were analyzed by HPLC for principal bioactive markers. The extracts were simultaneously tested in vitro for inhibition of human MAOs and antioxidant activity for analysis of correlation between phytochemical composition of the extracts and bioactivities.Materials and methods: Reversed-phase HPLC with photodiode array detection was employed to profile the alkaloidal and non-alkaloidal components of the aqueous extract of Banisteriopsis caapi. The Banisteriopsis caapi extracts and standardized compositions were tested in vitro for inhibition of recombinant preparations of human MAO-A and MAO-B. In vitro cell-based assays were employed for evaluation of antioxidant property and mammalian cell cytotoxicity of these preparations.
Results
Among the different aerial parts, leaves, stems/large branches and stem bark of Banisteriopsis caapi, HPLC analysis revealed that most of the dominant chemical and bioactive markers (1, 2, 5, 7-9) were present in high concentrations in dried bark of large branch. A library of HPLC chromatograms has also been generated as a tool for fingerprinting and authentication of the studied Banisteriopsis caapi species. The correlation between potency of MAO inhibition and antioxidant activity with the content of the main active constituents of the aqueous Banisteriopsis caapi extracts and standardized compositions was established. Phytochemical analysis of regular/commercial Banisteriopsis caapi dried stems, obtained from different sources, showed a similar qualitative HPLC profile, but relatively low content of dominant markers 1, 2, 7, and 9, which led to decreased MAO inhibitory and antioxidant potency compared to Banisteriopsis caapi Da Vine.
Conclusion
The ethnopharmacological use of bark of matured stem/large branch of Banisteriopsis caapi as well as whole matured stem is supported by the results obtained in this investigation. Among various constituents of Banisteriopsis caapi, harmine (7), harmaline (6) and tetrahydroharmine (5) are responsible for MAO-A inhibition, while two major proanthocyanidines, epicatechin (8) and procyanidine B2 (9) produce antioxidant effects. The compounds 1-9 can serve as reliable markers for identification and standardization of Banisteriopsis caapi aerial parts, collected in different seasons and/or from different geographical regions.
Research Summary of 'Composition, Standardization and Chemical Profiling of Banisteriopsis caapi, a Plant for the Treatment of Neurodegenerative Disorders Relevant to Parkinson’s Disease'
Introduction
Banisteriopsis caapi, a woody vine from the Amazon used traditionally as an ingredient of the psychoactive brew ayahuasca, contains β-carboline alkaloids that act as monoamine oxidase (MAO) inhibitors and has been reported to alleviate symptoms in neurological disorders including Parkinson’s disease. Earlier phytochemical studies identified harmine, harmaline and tetrahydroharmine (THH) among other β-carbolines, as well as various terpenoids. Recent work by the study team on a cultivated Hawaiian plant material named Da Vine additionally isolated two tetrahydro-β-carboline glycosides (banistenoside A and B), a new tetrahydronorharmine analogue, and antioxidant flavan-3-ols (epicatechin and procyanidin B2). Wang and colleagues set out to develop standardised aqueous extracts of B. caapi with high potency for inhibition of human MAOs and antioxidant activity, and to perform chemical profiling across plant parts, seasons and sources. The study aimed to quantify marker compounds (including β-carbolines and proanthocyanidins), formulate standardised pharmaceutical compositions from isolated markers, and test those preparations in vitro for MAO inhibition and antioxidant effects to explore correlations between phytochemistry and bioactivity.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topic
- APA Citation
Wang, Y., Samoylenko, V., Tekwani, B. L., Khan, I. A., Miller, L. S., Chaurasiya, N. D., Rahman, M. M., Tripathi, L. M., Khan, S. I., Joshi, V. C., Wigger, F. T., & Muhammad, I. (2010). Composition, Standardization and Chemical Profiling of Banisteriopsis caapi, a Plant for the Treatment of Neurodegenerative Disorders Relevant to Parkinson’s Disease. Journal of Ethnopharmacology, 128(3), 662-671. https://doi.org/10.1016/j.jep.2010.02.013
References (3)
Papers cited by this study that are also in Blossom
Callaway, J. C., Brito, G. S., Neves, E. S. · Journal of Psychoactive Drugs (2011)
Samoylenko, V., Rahman, M. M., Tekwani, B. L. et al. · Journal of Ethnopharmacology (2010)
Schwarz, M. J., Houghton, P. J., Rose, S. et al. · Pharmacology Biochemistry and Behavior (2003)
Cited By (3)
Papers in Blossom that reference this study
Alves, C. L., Cury, R. G., Roster, K. et al. · PLOS ONE (2022)
Kuypers, K. P. C. · Medical Hypotheses (2019)
Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Brain Research Bulletin (2016)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.